| Robyn Craven, Lily Stojanovska - 2001 - 284 Seiten
...menopausal women in the far East: Singapore segment. Maturatas 19: 199-204. McClung, MR et al. 2001. Effect of risedronate on the risk of hip fracture in elderly women. New England Journal of Medicine 344 (5): 333-40. McPherson, K. et al 1995. Breast Cancer - Epidemiology,... | |
| Kyle Moylan, Tammy L. Lin - 2004 - 236 Seiten
...McGarry KA, Kiel DP Postmenopausal osteoporosis. Postgrad Med 2000;108:79-91. McClungMR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-340. The MORE Investigators. Reduction of vertebral fracture risk in postmenopausal women... | |
| Bone and Tooth Society - 2002 - 66 Seiten
...corticosteroid therapy. Calcif Tissue Int 2000;67:277-85. 40 McClung MR, Geusens P, Miller PD, Zippel H et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-40. 41 Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral... | |
| Togas Tulandi - 2002 - 301 Seiten
...Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY. for the Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001; 344: 333-340. 57. Chesnut CH III, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel... | |
| Susan A. New, Jean-Philippe Bonjour - 2003 - 774 Seiten
...Fogelman. T. Diamond, R. Eastell, PJ Meunier and JY Reginster; Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women, N. Engl. J. Med.. 2001, 344(5),333-340. 40. F. Cosman, SR Cummings and R. Lindsay, How long should patients with osteoporosis... | |
| Patrice Lopès, Florence Trémollières - 2004 - 222 Seiten
...in women witb postmenopausal osteoporosis. JAMA 1999 ; 282 : 1344-1352. [6] MCÛ.UNG MR. GEUSENS P, MILLER PD et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl JMed 2001; 344: 333-340. Raloxifene [71 DELMAS PD, BJARNASON NH, MITLAK BH etal. Effects of raloxifene... | |
| Michael J. Maricic, Oscar S. Gluck - 2005 - 226 Seiten
...risedronate: a 5-year placebo-controlled clinical experience. Bone2003;32:120-128. 41 . McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl I Med 2001;344:333-340. 42. Cohen S, Levy RM, Keller M, et al. Risedronate therapy prevents corticosteroid-induced... | |
| Michael J. Maricic, Oscar S. Gluck - 2005 - 226 Seiten
...a 5-year placebo-controlled clinical experience. Bone 2003;32: 120- 128. 41. McClung MR, Ceusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Eng! I Med 2001:344:333-340. 42. Cohen S, Levy RM, Keller M, et al. Risedronate therapy prevents corticosteroid-induced... | |
| Nortin M. Hadler - 2004 - 340 Seiten
...physicians can, and should, make a difference. Ann Intern Med 1998; 129: 726-33. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. NEnglJ Med 2001 ; 344: 333-40. McDonald CJ. Medical heuristics: the silent adjudicators of clinical... | |
| Marianne J. Legato, John P. Bilezikian - 2004 - 696 Seiten
...with fracture as an endpoint. Endocr Rev. 23: 16-37. 25. McClung M, Geusens P, Miller PD elal. (2001). Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 344:333-340. 26. Cranney A, Guyatt G, Krolicki N elal. (2001). A meta-analysis of etidronate for the... | |
| |